Bosh sahifaA2RR34 • BVMF
add
Arrowhead Pharmaceuticals Inc
Yopilish kursi
8,08 R$
Yillik diapazon
7,24 R$ - 18,48 R$
Bozor kapitalizatsiyasi
1,86 mlrd USD
Oʻrtacha hajm
397,00
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,50 mln | -29,60% |
Joriy xarajat | 163,91 mln | 17,00% |
Sof foyda | -173,08 mln | -30,27% |
Sof foyda marjasi | -6,92 ming | -85,04% |
Har bir ulushga tushum | -1,39 | -12,10% |
EBITDA | -156,18 mln | -18,06% |
Amaldagi soliq stavkasi | -0,06% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 550,84 mln | 158,15% |
Jami aktivlari | 1,01 mlrd | 61,86% |
Jami passivlari | 957,62 mln | 111,59% |
Umumiy kapital | 56,08 mln | — |
Tarqatilgan aksiyalar | 126,10 mln | — |
Narxi/balansdagi bahosi | 19,24 | — |
Aktivlardan daromad | -37,48% | — |
Kapitaldan daromad | -40,94% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -173,08 mln | -30,27% |
Operatsiyalardan naqd pul | -146,27 mln | -24,13% |
Sarmoyadan naqd pul | 76,91 mln | 18,62% |
Moliyadan naqd pul | 20,63 mln | 7 628,09% |
Naqd pulning sof oʻzgarishi | -48,80 mln | 7,37% |
Boʻsh pul | -114,43 mln | 33,38% |
Haqida
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead’s products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
Tashkil etilgan
1-yan, 2004
Xodimlar soni
609
